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Abstract
Background: Squamous cells carcinoma is the most important malignant tumor with primary site
in the oral cavity and, given the great exposure of mucosa and lips to the etiologic factors of this
neoplasm, its incidence is high. Investigation of the prognostic determinants is significant for the
expectations of treatment proposal and cure of the patient. The local immune response
represented by peritumoral inflammatory infiltrate is a possible prognostic factor.
Methods:  In this study, oral mucosa samples of squamous cells carcinoma were analyzed,
separated according to their histological classification as well as the phenotypical profile of the cells
comprising the peritumoral inflammatory infiltrate was investigated by immunohistochemical
method, in addiction, the cell proliferation index via protein Ki67 expression was determinated.
Results: The T lymphocytes made up most of this inflammatory infiltrate, and among these cells,
there was a predominance of T CD8 lymphocytes relative to the T CD4 lymphocytes. The B
lymhocytes were the second most visualized leucocyte cell type followed by macrophages and
neutrophils. The immunohistochemical assessment of Ki-67 positive cells revealed a greater
expression of this protein in samples of undifferentiated squamous cells carcinoma.
Conclusion: The results suggest that the cellular immune response is the main defense mechanism
in squamous cells carcinoma of oral mucosa, expressed by the large number of T lymphocytes and
macrophages, and that the greatest intensity of local response may be associated with the best
prognosis.
Background
Malignant neoplasms of the mouth comprise a heteroge-
neous group of lesions that differ among themselves as to
risk factors, clinical aspects, and histologic origin. Among
the different tumors of this group, squamous cells carci-
noma is the most prevalent histologic type and represents
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most cases of diagnosed oral cancer [1-4]. Despite preven-
tion campaigns of several governmental health care pro-
grams and expansion of the network of specialized
professionals who prioritize the diagnosis of premalig-
nant lesions of the mouth in the different health care serv-
ices currently active, 7% of the world's population is
affected by oral cancer, and it is, therefore, a worldwide
health concern [4].
Squamous cells carcinoma originates in the epithelium
that lines the mouth. This fact is extremely important
when we consider the constant exposure of the oral cavity
to local intrinsic stimuli associated with the increased risk
of this type of cancer. Among the main risk factors, smok-
ing, chronic alcoholic beverage consumption, and chronic
mechanical traumas – such as maladapted dental prosthe-
ses and fractured teeth – stand out. Furthermore, includ-
ing primary cancer of the lips, especially of the inferior
portion, we should consider continuous exposure to solar
radiation as a significant extrinsic factor, especially in leu-
kodermic individuals. Besides local intrinsic factors and
extrinsic factors, the patient's genetic predisposition and
immune response are determining factors in the risk for
cancer [2,4-10].
In addition to the intensification in prevention activities,
several studies have been developed to establish the deter-
mining factors of the prognosis for these lesions with the
objective of minimizing morbidity and mortality caused
by the existing malignant lesion. Many authors have
investigated a possible correlation between the patient's
immune response, neoplastic behavior, and prognosis
[5,11,12].
Meneses et al., (1998) demonstrated, in oral squamous
cells carcinoma samples, a possible association between
tumor size, area of invasion, angiogenesis, and the pheno-
typical characterization of the peritumoral inflammatory
infiltrate predominantly comprised by T lymphocytes and
B lymphocytes. Coussens et al., (1999) also found in car-
cinomas of oral mucosa an association between the pre-
dominance of mast cells in the peritumoral infiltrate and
a greater development of the stromal angiogenesis, which
would provide adequate blood supply for neoplastic
nutrition, and consequently, a poorer prognosis.
Along with the evaluation of the peritumoral inflamma-
tory infiltrate and its products, the study of tumoral cellu-
lar kinetics, its regulating mechanisms and its inter-
relationship with growth factors, oncogenes and anti-
oncogenes has also been the target of several studies
[8,15-19].
Among the cellular events that directly determine the
tumor's clinical progress, cellular proliferation is signifi-
cant, i.e., disorders in the number of cells resulting from
dysfunctions in the mitotic cycle [20,21].
The proliferative activity of any tissue or neoplasm can be
determined by its growth rate using antibodies directed
against specific antigens expressed by proliferating neo-
plastic cells, allowing the simultaneous analysis of cell
proliferation and histology [13,22,23]. The Ki67 molecule
has been the antigenic marker of choice, since it does not
suffer much influence from internal and external factors,
and its nuclear expression during a defined period of the
cell's cycle represents an advantage in its use as a biologi-
cal marker of mitotic activity [24-27].
Recently it was demonstrated that Ki-67 gene suffers "over
expression" in epithelial cells of pre-malignant and malig-
nant oral lesions.
In this study the cell proliferation index was evaluated by
means of the expression of protein Ki67 and the pheno-
typical profile of cells that comprise the peritumoral
inflammatory infiltrate in samples of squamous cells car-
cinoma of oral mucosa. The results demonstrated a vital
participation of the population of T lymphocytes in the
composition of the inflammatory infiltrate associated
with the neoplasic area. These results also suggest a corre-
lation between the intensity of the peritumoral inflamma-
tory reaction and the proliferation of tumor cells.
Methods
Samples of oral mucosa squamous cells carcinoma from
treatment naïve patients submitted to diagnostic inci-
sional biopsies. Paraffin-blocked samples (n = 30) were
obtained from the archives of the Pathological Anatomy
Laboratory of the Medical School of the Dom André
Arcoverde Foundation – Valença/RJ.
The blocks were processed histologically to obtain slices 4
μm thick and stained with routine hematoxylin and eosin
(HE).
Slides were evaluated by two different examiners, and the
tumors were classified histologically according to the
International Classification of Diseases for Oncology
(ICD-O/2000). Samples were divided into the following
groups:
Group 1: well-differentiated squamous cells carcinoma of
oral mucosa (n = 10)
Group 2: moderately differentiated squamous cells carci-
noma of oral mucosa (n = 10)
Group 3: undifferentiated squamous cells carcinoma of
oral mucosa (n = 10).BMC Oral Health 2008, 8:25 http://www.biomedcentral.com/1472-6831/8/25
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Histomorphometry of the inflammatory infiltrate
In order to quantify the peritumoral inflammatory infil-
trate, Scion Image software and FotoScan software were
used for image capture and morphometry of the inflam-
matory infiltrate. All samples were captured in full extent
and fields (original magnification 100×) with inflamed
areas around the tumor were measured semi-automati-
cally, with manual selection of the inflamed region and
computed analysis of the selected area.
Based on the analysis of each sample, simple arithmetic
means the inflamed area per microscopic field were
obtained and the results were expressed in percentage of
inflamed peritumoral area per group.
Immunohistochemical Analysis
Slices with 4 μm thickness arranged on silanized slides (3-
aminopropyltriethoxysilane; Sigma Chemical, Co; USA),
were deparaffinized in a 60°C chamber, and sequentially
hydrated in passages through xylol, absolute alcohol, 70%
alcohol, and distilled water.
The classic avidin-biotin peroxidase anti-peroxidase com-
plex method was used in studying the samples. Samples
were submitted to antigen retrieval with immersion of the
fragments in 0.001 M citrate buffer, PH 6.0, and peroxi-
dase block with 3% hydrogen peroxide and further incu-
bated for 1 hour with the primary antibodies specified on
Table 1. Next, they were incubated with secondary bioti-
nylated antibodies for 30 minutes and submitted to a
reaction with the avidin-biotin complex for another 30
minutes. Staining was performed by the addition of the
diaminobenzidine chromogen (DAB) substrate for about
1 minute.
Negative control of the immunohistochemical reaction
was performed by omitting incubation with the primary
antibody for some slices. Slices were analyzed and phot-
omicrographs were made with the Nikon Microphot sys-
tem (Tokyo, Japan).
Reactive cell count for each antibody was made by scan-
ning the entire sample, with 400× magnification, with a
count of positive cells in all fields. Results were obtained
from the simple arithmetic mean and expressed in per-
centage of positive cells per microscopic field.
Statistical Analysis
Statistical analysis was performed using Mann-Whitney
with a p < 0.05 significance level in order to comparatively
evaluate means of the parameters analyzed in the different
groups of the experiment.
Results
The histopathology analysis of the slices stained with
hematoxylin and eosin (HE) and submitted to morpho-
metric analysis revealed that the mean percentage of peri-
tumoral inflamed area per microscopic field was 24.7% in
Group 1 (samples of well-differentiated squamous cells
carcinoma of the oral mucosa) (Figure 1a), 33.2% in
Group 2 (samples of moderately differentiated squamous
cells carcinoma of the oral mucosa) (Figure 1b), and
42.6% in Group 3 (samples of undifferentiated squamous
cells carcinoma of the oral mucosa) (Figure 1c). After sta-
tistical evaluation, the amount of peritumoral inflamed
area showed a statistically significant difference when
Groups 1 and 3 were compared (p < 0.05) (Figure 2).
In all the samples evaluated in this study, the quantitative
predominance of the inflammatory infiltrate was directly
associated with areas of greatest invasion into tissues sub-
jacent to the tumor parenchyma.
The phenotypical evaluation of the peritumoral infiltrate
was carried out by identification of inflammatory cell pos-
itivity, characterized by the visualization of light brown
intracellular coloring, against a background counter-
stained with hematoxylin in each one of the reactions for
the antibodies used.
In all groups, analysis of the immunohistochemical anal-
ysis showed the presence of an inflammatory reaction
constituted predominantly by mononuclear inflamma-
tory cells. The T lymphocytes made up most of this
inflammatory infiltrate, and among these cells, there was
a predominance of T CD8 lymphocytes relative to the T
CD4 lymphocytes (Figure 3a). The B lymphocytes were
the second most visualized leukocyte cell type (Figure 3b),
followed by macrophages (Figure 3d) and neutrophils
(Figure 3c).
There was no significant difference when leukocyte types
of the three groups were compared (p > 0.05) (Figure 4).
In samples of patients from Group 1, the immunohisto-
chemical assessment of protein Ki-67 revealed scarce
immunoreactive tumor cells (20% ± 3,2) (Figure 5), while
in samples of patients from Group 2, cells with positivity
were more abundant (47% ± 6,3). In samples of Group 3
patients, cells marked positively represented 60.3% ± 2,8
Table 1: Antibodies for immunohistochemistry analysis Antibody 
Marking Brand
Anti CD20 B Lymphocytes Dako
Anti CD3 T Lymphocytes Dako
Anti CD8 Regulatory T Lymphocytes Dako
Anti CD4 Helper T Lymphocytes Dako
Anti CD15 Neutrophils Dako
Anti CD68 Macrophages Dako
Anti Ki67 Cellular proliferation DakoBMC Oral Health 2008, 8:25 http://www.biomedcentral.com/1472-6831/8/25
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of the malignant tumor cells. The comparison between
the percentages of tumor cells positive for Ki-67 expres-
sion per microscopic field in the oral mucosa samples of
the three groups showed statistically significant differ-
ences (p < 0.05) (Figure 6). Tumors from Group 3 showed
a greater expression of protein Ki-67 compared to the
tumors from Groups 1 and 2.
Discussion
Squamous cells carcinoma is the most prevalent type of
cancer of the oral mucosa, and represents 91% of the diag-
nosed cases of malignant tumors of the mouth [2,6-8].
Besides the multifactor etiology involving extrinsic and
intrinsic factors, the patient's immune status is also con-
sidered to influence the risk of cancer and determine sev-
eral aspects of its progression [4,9,10]. In the 1980s,
Scully C. (1983) had already recognized the involvement
of the immune response in the development of malignant
mouth tumors, and had emphasized that future cancer
treatment would be based on immunotherapy through
immunomodulation.
Among the events that directly determine tumor clinical
progression, those of primary importance include disor-
ders in the number of cells resulting from mitotic cycle
dysfunctions and possible failures" in host's immune eva-
sion of the tumors – assessed by the intensity of the peri-
tumoral inflammatory infiltrate, inflammatory cell
Morphological grading of squamous cells from the buccal  mucosa Figure 1
Morphological grading of squamous cells from the 
buccal mucosa. A: Well-differentiated squamous cell carci-
noma of buccal mucosa. N = 10. HE stain. Original magnifica-
tion 200×. B: Moderately differentiated squamous cell 
carcinoma of buccal mucosa. N = 10. HE stain. Original mag-
nification 400×. C: Undifferentiated squamous cell carcinoma 
of buccal mucosa. N = 10. HE stain. Original magnification 
400×.
Intensity of peritumoral inflammatory infiltrate Figure 2
Intensity of peritumoral inflammatory infiltrate. Val-
ues are expressed in simple arithmetic means ± sd. Statistical 
significant difference was observed when compared groups 1 
and 3. p ≤ 0.05.BMC Oral Health 2008, 8:25 http://www.biomedcentral.com/1472-6831/8/25
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composition, cytokine production by infiltrate cells, and
presence of angiogenesis [11,12,14,20,21].
According to Costa L. et al., (2005) in a retrospective clinical
study with 38 samples of oral squamous cells carcinoma,
the TNM classification (tumor staging determined by the
size of the primary cancer and the presence of metastases)
correlates with the chief histopathologic characteristics of
tumoral classification – degree of keratinization, nuclear
pleomorphism, and intensity of peritumoral lymphocytic
infiltration, and the link among these data is important in
determining prognosis and choosing treatment.
The present results showed an inverse correlation between
the degree of tumor differentiation and the rate of cell
proliferation obtained by the expression of protein Ki67.
Results similar to those found in this study are also sug-
gested by Costa et al., (2005) in oral carcinoma, Glen et
al., (2006) in malignant pancreatic lesions, Deans et al.,
(2006) in gastro-esophageal cancers, and Cai et al.,
(2006) in transitional cell carcinoma of the bladder. The
undifferentiated tumors showed an accentuated expres-
sion of protein KI-67. Aguiar (1996) demonstrated that
the mitotic index increases progressively from normal per-
itumoral oral mucosa towards tumor areas, as well as in
areas of greatest tissue invasion [7]. Pich et al., (2004) in
a retrospective study with malignant lesions of the mouth
cavity, salivary glands, pharynx, and larynx, observed that
the proliferative activity investigated by different methods
– such as the AgNORs Index determination and MIB-1
and Ki67 expression by immunohistochemistry – is clini-
cally relevant and valid for proposing treatment and
defining prognosis. In this paper, the histologic character-
istics exhibited by the malignant tumor were associated
with the clinical aggressiveness by the analysis of the
malignant grade related to possible determinants of lesion
prognosis – local immunologic profile and malignant cell
proliferation.
Immunohistochemistry for phenotypical characterization of peritumoral inflammatory infiltrate Figure 3
Immunohistochemistry for phenotypical characterization of peritumoral inflammatory infiltrate. A: lym-
phocytes T (CD3+ cells). Original magnification 400×. B. A: lymphocytes B (CD20+ cells). Original magnification 400× C. A: 
Neutrophils (CD15+cells). Original magnification 400× D. A: Macrophages (CD68+cells). Original magnification 400×.BMC Oral Health 2008, 8:25 http://www.biomedcentral.com/1472-6831/8/25
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According to the results obtained from morphometry of
the peritumoral infiltrate, the average percentage of
inflamed area per microscopic field was greater in the
undifferentiated tumors (Group 3) when compared to the
averages of the moderately differentiated tumor samples
(Group 2), followed by the well-differentiated tumor
samples (Group 1). In evaluating these data, we noted
that there is a correlation between the highest degree of
malignity and the greatest inflammatory intensity.
The characterization of the peritumoral infiltrate compo-
sition did not reveal a difference between the leukocyte
types of the three groups, determined from their grades,
but interestingly, the quantities of each cell type were
equally proportional in these groups. We note that in all
samples, the total number of T lymphocytes and macro-
phages predominated over the quantification of plasmo-
cytes, characterizing the patient's local reaction as a
predominantly cell type immune response.
In addition to the evaluation of the peritumoral inflam-
matory infiltrate intensity and its cellular components,
some of the major determinants of tumor aggressiveness
and possible predictors of prognosis are alterations in cell
proliferation, i.e., abnormalities in the number of cells
resulting from mitotic cycle dysfunctions. This neoplastic
proliferative activity can be determined by the growth rate
by means of Ki67 expression [18-21,28-31].
Cellular profile of the peritumoral inflammatory infiltrate Figure 4
Cellular profile of the peritumoral inflammatory infil-
trate. Values are expressed as simple arithmetic means ± sd. 
No statistical significant difference was observed when com-
pared the groups. p ≤ 0.05.
Immunohistochemistry demonstrating expression of protein  Ki67 in malignant tumor cells from samples of oral mucosa  squamous cells carcinoma Figure 5
Immunohistochemistry demonstrating expression of 
protein Ki67 in malignant tumor cells from samples 
of oral mucosa squamous cells carcinoma. A: Well-dif-
ferentiated carcinoma. Original magnification 400×. B: Mod-
erately differentiated carcinoma. Original magnification 400×. 
C: Undifferentiated carcinoma. Original magnification 400×.BMC Oral Health 2008, 8:25 http://www.biomedcentral.com/1472-6831/8/25
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The comparison among the percentages of tumor cells
positive for the expression of Ki-67 per microscopic field
in the oral mucosa samples of the three groups showed
statistically significant differences. The samples from
Group 3 (undifferentiated squamous cells carcinoma of
the oral mucosa) displayed a greater expression of cells
marked positively, followed by the samples of patients
from Group 2 (moderately differentiated squamous cells
carcinoma of the oral mucosa), and from Group 1 (well-
differentiated squamous cells carcinoma of oral mucosa).
As to leukocyte characterization, Sica et al., (2006)
reported evidence associated to the predominance of the
macrophage population in the peritumoral infiltrate and
a greater promotion of tumoral angiogenesis, attributing
to these cells a pro-tumoral role, and consequently, a poor
prognosis.
In the samples studied of oral carcinoma, the evaluation
of peritumoral inflammatory cells demonstrated the
importance of cellular immunity in the local antineoplas-
tic response due to the presence of a population predom-
inantly composed of T lymphocytes and macrophages,
albeit with no relevant differences as to the infiltrate com-
position according to the histological grading.
Recently, in samples of invasive breast cancer, we investi-
gated the possible correlation between the intensity of the
peritumoral inflammatory infiltrate and the degree of
tumor differentiation [32]. We point out that when we
analyzed patients with malignant tumors of the same
grade, those who progressed satisfactorily showed a more
intense peritumoral inflammatory response, while those
who experienced tumor relapses and metastatic dissemi-
nation developed a less intense peritumoral inflammatory
response.
Conclusion
In this study, the parallel between intensity of the inflam-
mation and the patient's prognosis has not yet been fully
clarified, and further research is needed. The distribution
of the oral mucosa carcinoma samples into groups was
made according to histologic grading. The results suggest
a positive correlation between inflammatory response
intensity and the degree of tumor differentiation. There-
fore, undifferentiated tumors present a greater develop-
ment of the peritumoral inflammatory process when
compared to moderately differentiated and well-differen-
tiated tumors. Nevertheless, in order to define this varia-
ble of inflammatory response intensity as a prognostic
factor in oral cancer, other studies should be carried out so
that the intensity of the local response and malignant cell
proliferation in tumors of the same histopathologic clas-
sification associated to the patients' clinical progress can
be evaluated.
Finally, the results presented in this study suggest that the
cellular immune response is the main defense mechanism
in oral mucosa squamous cells carcinoma, expressed by
the large number of T lymphocytes and macrophages.
We further underscore that Ki-67 expression is related to
the mitotic index and, consequently, to cellular prolifera-
tion and malignant grading of the neoplasm.
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